Inhibitors of hydrogen sulfide biosynthesis: preclinical development of novel colorectal cancer therapies

Project: Other project

StatusFinished
Effective start/end date12/1/145/30/18

Funding

  • Cancer Prevention and Research Institute: $627,172.58